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a  b  s  t  r  a  c  t
In low  endemicity  areas  of schistosomiasis,  the  recommended  diagnostic  method  of copro-
logical examination  results  in  an  underestimation  of infection  cases.  Alternative  diagnostic
methods  have  been  developed,  such  as  immunodiagnostic  and  molecular  techniques.  In  this
study we evaluated  three  methods  used  in the  diagnosis  of  Schistosoma  mansoni  infection:
parasitological  (Kato-Katz),  immunological  (ELISA)  and  molecular  (real  time  PCR),  and  also
investigated the sensitivity  of  each  technique  in  the  cure  determination  after  treatment
with  praziquantel  using  the  water  rat  Nectomys  squamipes,  a natural  reservoir  for  S.  man-
soni,  as  an  experimental  model.  Two  infection  laboratory  experiments  were  carried  out. The
ﬁrst experiment  aimed  to observe  the  evolution  of  the  immunological  response  in the  ﬁrst
moments  after  infection  and  in the  ﬁrst  months  after  treatment.  The  second  experiment
aimed  to compare  the  efﬁcacy  of  the three  diagnostic  techniques  after  infection  and  after
treatment over  a  more  extended  time  period.  In  the  ﬁrst  experiment,  44%  of the  infected
animals  showed  IgG  reactivity  after  two  weeks  of  infection,  and  94%  were  positive  based
on serology  30  days  after infection.  The  serological  IgG  titers  increased  just after  infec-
tion but  decreased  gradually  after  treatment.  In  the  second  experiment,  89%  of the  animals
showed positive  IgG titers  22  days  after  infection.  Only  68%  of  the  animals  showed  posi-
tive results  on  the  coproscopic  diagnostic  analysis  and  79% did  so  by  qPCR,  50  days  after
infection.  Treated  animals  showed  negative  results  on  coproscopy  one  month  after  treat-
ment but  remained  positive  by  serology  even  12 months  after  treatment,  although  showing
a decline  in  immunologic  reaction  after  treatment.  By qPCR  analysis,  all animals  showed
negative  results  three  months  after  treatment,  except  for one  animal.  The  parasitosis  can
be detected  by coproscopy  only  six  weeks  after  infection,  and  by  serology  14  days  after
infection.  The  qPCR  was  a better  diagnostic  method  for  conﬁrming  the infection  cure of  S.
mansoni.  In early  infection,  this  method  was  less  efﬁcient  than  serology  but  was slightly
∗ Corresponding author. Tel.: +55 21 25621253; fax: +55 21 25621253.
E-mail addresses: rgentile@ioc.ﬁocruz.br (R. Gentile), margaremaria@yahoo.com.br (M.M.L. Gonc¸ alves), socrates@ioc.ﬁocruz.br (S.F. da Costa Neto),
maristellamatosdacosta@hotmail.com (M.M.  da Costa), rperalta@vm.uff.br (R.H.S. Peralta), peralta@micro.ufrj.br (J.M. Peralta).
304-4017 ©  2011 Elsevier B.V. 
oi:10.1016/j.vetpar.2011.03.007
Open access under the Elsevier OA license.
244 R. Gentile et al. / Veterinary Parasitology 180 (2011) 243– 249
more  efﬁcient  than  the  Kato-Katz  method.  We  suggest  that  the  methods  should  be used in
low  endemic  areas  as follows:  serology  should  be  used  in the  initial  diagnosis  in  a  population
with  potential  positive  cases;  subsequently,  coproscopy  should  be used  in  IgG positive  cases
to  conﬁrm  the  current  infection;  and  qPCR  should  be used  to  evaluate  the  infection  cure
after  treatment  and  is  also a very  valuable  tool  when  there  are  cases  showing  positive  IgG
scopy.and  negative  copro
1. Introduction
Schistosomiasis is still considered one of the most
important chronic parasitic diseases in tropical regions and
affects  approximately 200 million people, despite the con-
tinued  implementation of control measures (WHO, 2010).
However, currently, severe cases and deaths caused by
Schistosoma mansoni seldom occur in several endemic
areas. In such areas, where schistosomiasis has a low
incidence and a low severity of infection, the parasitic
burden is very low but the worms may  become resis-
tant after chemotherapy treatment. In these cases, the
currently recommended diagnostic method for schistoso-
miasis (coprological examination by Kato-Katz technique)
results in an underestimation of infection cases with
several false-negatives (Gonc¸ alves et al., 2006). For this
reason, alternative diagnostic methods have been devel-
oped.  In those countries where there are numerous areas
of  low endemicity or isolated outbreaks of schistosomia-
sis, immunological methods have been incorporated into
their  programs for disease control (Bergquist, 1992; Noya
et  al., 1998). Immunodiagnostic techniques may  be used
to  detect circulating antigens of Schistosoma and to detect
antibodies produced against the parasite (Rabello, 1997).
However, in some cases, the immunologic diagnosis is
not  species-speciﬁc or may  not detect cured infection
in the short term (Doenhoff et al., 2004; Duus et al.,
2009).
Recently, molecular techniques that use polymerase
chain reaction (PCR) have been developed for diagnoses
that are more sensitive and speciﬁc for the detection of
S.  mansoni (Pontes et al., 2002, 2003; Rabello et al., 2002).
Sandoval et al. (2006a) established a new PCR approach and
successfully applied it to urine samples of patients, which
indicated a high sensitivity and speciﬁcity of the technique.
In  a laboratory experiment, Sandoval et al. (2006b) com-
pared  the performance of this new PCR approach with the
Kato-Katz and ELISA diagnostics in mice, which conﬁrmed
the  greater sensitivity of the PCR technique. A multiplex
real-time PCR was developed for the S. mansoni and Schis-
tosoma  hematobium diagnosis and quantiﬁcation and was
found  to be a powerful tool for epidemiological studies
(Ten Hove et al., 2008). Allam et al. (2009) studied the
true  prevalence and intensity of S. mansoni before and
after  treatment in areas of low endemicity using Percoll
density centrifugation and PCR techniques. They found a
marginal  error of 11% using the Percoll technique compared
with  the Kato-Katz technique and showed that Percoll
and PCR were more efﬁcient. PCR detected more posi-
tive  cases than both other techniques but missed some
cases that were conﬁrmed positives by parasitological
examinations.© 2011 Elsevier B.V. 
Another problem concerning schistosomiasis is the
development of resistance to some drugs. Currently,
praziquantel is the most commonly used drug for schis-
tosomiasis treatment and is recommended by the WHO;
however, there is a growing concern related to its resis-
tance. Some authors detected S. mansoni populations,
which were resistant to praziquantel (Bonesso-Sabadini
and Dias, 2002; Doenhoff et al., 2002). There have been
no  studies that evaluated the efﬁcacy of the drugs used
in  schistosomiasis treatment in low endemic areas. This
efﬁcacy could be evaluated experimentally using wild host
species  that are found in those endemic areas. The persis-
tence  time of the antibodies after the therapeutic cure can
also  be determined using more sensitive diagnostic meth-
ods  in these low endemic areas.
In this study, we  evaluated three methods used in the
diagnosis of S. mansoni infection: parasitological (Kato-
Katz), immunological (ELISA) and molecular (real time
PCR  – qPCR). We  also investigated the sensitivity of
each technique in the determination of cure after treat-
ment with praziquantel using the water rat Nectomys
squamipes experimental model (Rodentia, Sigmodonti-
nae); this rodent is a natural reservoir for S. mansoni
infection (Rodrigues-Silva et al., 1992; Silva et al., 1992;
D’Andrea et al., 2000; Gentile et al., 2006).
2. Materials and methods
2.1.  Animals and the experimental infections
Two infection experiments were carried out. In the
ﬁrst experiment, 18 rodents of the species N. squamipes
were used, and in the second experiment, twenty two of
these  rodents were used. All animals were young adults
with an age range of 75–135 days old for both sexes.
These animals were bred in captivity at the Wildlife Ani-
mal  Breeding Center of Fundac¸ ão Oswaldo Cruz. Animals
were kept under conventional conditions (22–26 ◦C tem-
perature, natural daylight). Water and food were provided
ad  libitum. The diet consisted of NUVILAB CR1 mouse pellets
(Nuvital Nutrients S.A., Colombo, PR, Brazil). Animal breed-
ing  was carried out under the authorization of the Brazilian
Government Institute for Wildlife and Natural Resources
Care (license number 02022.002062/01-04) and accord-
ing  to the Ethical Commission on Animal Use of Fundac¸ ão
Oswaldo  Cruz (license number L-030/07). The experimen-
Open access under the Elsevier OA license.tal  procedures were also conducted according to the Ethical
Commission on Animal Use of Fundac¸ ão Oswaldo Cruz
(license number L-027/09).
The  S. mansoni isolate used for the infection was
obtained from Sumidouro Municipality, Rio de Janeiro,
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razil. This locality is an endemic area of schistosomi-
sis and consisted of both low and high endemic areas
here naturally infected N. squamipes rodents can be found
Gentile  et al., 2006).
The  main aim of the ﬁrst experiment was to observe
he evolution of the immunological response in the ﬁrst
ays  after infection and in the ﬁrst months after treatment.
n  this laboratory experiment, 15 animals were infected
ith 500 cercariaes of S. mansoni. Three animals were used
s  controls and were not infected. Of the 15 infected ani-
als,  ten were treated with a single dose of praziquantel
Merck, Whitehouse Station, NJ, USA) 49 days after the
nfection. The drug was administrated orally, using a ster-
le  probe, at a dose of 250 mg/kg. The drug was macerated
nd diluted in Cremophor EL (Sigma–Aldrich, St. Louis, MO,
SA).  Eight animals were sacriﬁced 15 days after treatment.
ive  of them were treated, and three provided veriﬁca-
ion of the infection success. The remaining animals were
acriﬁced six months after infection. In this ﬁrst experi-
ent, only coproscopic and serological methods were used.
oproscopy was used 42 and 49 days after infection and
hen  every week for two months after treatment. Serol-
gy  analyses were carried out to verify the evolution of
he  humoral immunologic response. This analysis was  con-
ucted  at the following times: prior to infection, weekly
etween infection and treatment, every 15 days during the
rst  three months after treatment, and then monthly until
ix  months after infection.
In  the second experiment, we aimed to compare the
fﬁcacy of the three diagnostic techniques after infection
nd  after treatment over a more extended time period.
ineteen animals were infected in the laboratory with the
dentical  parasitic burden that was used in the ﬁrst exper-
ment.  Three animals were used as controls and were not
nfected. Sixty-ﬁve days after infection, 12 animals were
reated  with the same dose of praziquantel (Merck) that
as  used in the ﬁrst experiment. Six animals were sac-
iﬁced 30 days after treatment. Three of them received
he drug and the other three provided veriﬁcation of the
nfection success. The remaining animals were sacriﬁced 12
onths  after infection. Three S. mansoni diagnostic meth-
ds  were used in the second experiment: coproscopic,
erologic and molecular (qPCR). Coproscopic analyses were
onducted  50 days after the infection, and at one and six
onths  after treatment. Serological diagnostics were con-
ucted  prior to infection, 22 and 50 days after infection, and
ne,  three, six and 12 months after treatment. For qPCR
nalyses, feces samples from 50 days after infection, and
rom  three, six and 12 months after treatment were used.
At  each necropsy, adult worms were searched and
ecovered by perfusion of the hepatoportal system of all
nimals.
.2.  Diagnostic techniques
.2.1.  Parasitological examination
Coproscopic  analyses were conducted using the Kato-
atz  technique (Katz et al., 1972). Feces were collected
irectly from the boxes in which the animals were housed.
ach  animal was transferred to a clean box, and feces were
ollected 24 h later.ology 180 (2011) 243– 249 245
2.2.2. ELISA
For  serological analysis, blood samples from each ani-
mal  were collected via a small puncture of the caudal vein
using  a sterile needle. Samples were transferred to a 1.5 ml
tube  and centrifuged for serum separation. Serum samples
were  kept at −20 ◦C until used. ELISA (IgG) was  performed
as described by Peralta et al. (2009). S. mansoni mem-
brane extract was used as the antigen and rabbit anti-N.
squamipes immunoglobulins were labeled with peroxi-
dase  and used as the secondary antibody. Serum samples
from experimentally infected and non-infected animals
were used as controls in all ELISA tests. Serum samples
were diluted 1:100, and the conjugate antibody IgG anti-
IgG  N. squamipes was  diluted 1:2000. This procedure was
repeated for each plate of the ELISA test. The results of
the  analysis were expressed in immunoenzymatic units in
the  ratio of the optical density of the test sample divided
by  the daily cut-off. The cut-off was  determined based on
the  average of the optical density ± 3SD of ten negative
serum samples of N. squamipes rodents that were bred
in  the laboratory. Immunologic evolution of the infection
and  treatment were observed graphically using GraphPad
Prism 5.
2.2.3.  DNA extraction and qPCR
For speciﬁc qPCR, total genomic DNA was extracted
from stool specimens using a modiﬁcation of the FastDNA®
method (Qbiogene, Carlsbad, CA, USA) as previously
described (Da Silva et al., 1999). DNA was extracted from
300  l of each clinical specimen. Samples were disrupted
in the FP120 cell disruptor instrument (Qbiogene) at a
speed  of 5.5 for 10 s. Potential inhibitors were removed
by further puriﬁcation with the QIAquick PCR puriﬁca-
tion kit (Qiagen Inc., Valencia, CA, USA) according to the
manufacturer’s instructions. Puriﬁed DNA was  stored at
−20 ◦C until used in qPCRs. For the detection of S. mansoni-
speciﬁc DNA, the primers Smcyt748F and Smcyt847R were
selected  to amplify a fragment of 99 bp, which is detected
by  the double-labeled probe, Smcyt785T-FAM (Ten Hove
et  al., 2008). For the ampliﬁcation, 5 l of DNA extracted
from stool specimens was  used as a template (sample,
negative and positive DNA controls) with 15 l of Mas-
ter  Mix  (Platinum Quantitative PCR Supermix-UDG with
ROX  – Invitrogen, Carisbad, CA, USA) added with primers
and probe, resulting in a total reaction volume of 20 l.
Primers and probe were used at 1.1 pmoles and 2.75 pmoles
concentrations, respectively. Each unknown sample was
diluted  1:2 and 1:40, and both dilutions were used in the
assay.  Ampliﬁcation consisted of 15 min  at 95 ◦C followed
by  40 cycles of 15 s at 95 ◦C and 1 min  at 60 ◦C. Ampliﬁca-
tion, detection and data analysis were performed with the
Applied  Biosystems 7500 Real Time PCR System (Applied
Biosystems, Foster City, CA, USA).
3. ResultsIn the ﬁrst experiment, 44% of the infected animals
showed IgG reactivity after two  weeks of infection, and
94%  were positive based on serology 30 days after infec-
tion  (Fig. 1), which conﬁrmed the high sensitivity of this
diagnostic method for early infection. Only one animal did
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Bonesso-Sabadini and Dias, 2002; Doenhoff et al., 2002;Fig. 1. Schistosoma mansoni IgG antibody titers for each animal of Necto-
mys  squamipes after experimental infection showing the evolution of the
immune response along time.
not show IgG reactivity. The serological IgG titers increased
just  after infection but decreased gradually after treatment.
Coproscopic exams showed positive results six weeks after
infection,  except for two animals, which showed positive
results after seven and eight weeks of infection, respec-
tively. All treated animals showed negative results in
the  coproscopy 15 days after treatment, except for one
animal, which showed negative results 21 days after treat-
ment.  However, all treated animals remained positive on
the  serologic exams until ﬁve months after treatment,
except for one animal, which showed negative results three
months  after treatment. Final necropsy (six months after
the  infection) ﬁndings showed that no adult worms were
recovered from the treated animals and revealed a low bur-
den  in the non-treated animals.
In the second experiment, 89% of the animals showed
positive IgG titers 22 days after infection. One animal con-
verted  to positive 50 days after infection and one only
three months after infection. Both animals showed neg-
ative  results on the coproscopy but were positive by qPCR.
Only  68% of the animals showed positive results on the
coproscopic diagnostic analysis and 79% did so by qPCR,
50  days after infection (Table 1).
Among the treated animals, three were necropsied one
month  after treatment. No worms were recovered in those
animals, and they showed negative results on coproscopy
and positive results by serology. The other treated ani-
mals  showed negative results on coproscopy one month
after  treatment but remained positive by serology even 12
months  after treatment. However, there was a conspicuous
decline in immunologic reaction after treatment (Fig. 2). By
qPCR  analysis, all animals showed negative results three
months after treatment, except for one animal, which
showed negative results six months after treatment. On
the  ﬁnal necropsy of those treated animals, no worms were
observed  and negative results were observed by qPCR and
positive  results by serology.
Among the non-treated animals, three were necropsied
95 days after infection. All of these animals showed adult
worms and positive IgG titers, but only one was  positive
on  coproscopy. Two animals were necropsied 12 months
after  treatment, and both showed adult worms and positiveFig. 2. Schistosoma mansoni IgG antibody titers for each animal of Necto-
mys squamipes after experimental infection showing the evolution of the
immune response after treatment.
serology, but only one was positive by qPCR. Two  other
non-treated animals died during the experiment after ﬁve
months  of infection; both were IgG positive and one was
qPCR  positive.
Comparing the three diagnostic methods 50 days after
infection, we  observed that qPCR and coproscopy agreed
in  only 58% of the cases, whereas qPCR and serology,
and coproscopy and serology agreed in 74% of the cases.
Three months after infection coproscopy agreed with the
necropsy  in 60% of the cases, whereas coproscopy agreed
with  serology in 50% of the cases. On the ﬁnal necropsy,
fourteen months after infection, the qPCR agreed with the
necropsy  results in 90% of the cases, and the serology
agreed with the necropsy results only in 20% of the cases
which indicates that one year after chemotherapy treat-
ment,  animals still showed IgG reactivity, even without the
presence  of the parasite.
These  comparisons did not include the non-infected
control animals. All control animals were negative in all
diagnostic methods throughout the experiment.
4. Discussion
The use of N. squamipes as an experimental animal was a
great  advantage in the comparison of the diagnostic meth-
ods  for schistosomiasis studies, especially concerning the
cure  of infection. It permits the analysis of the evolution of
the  infection and the immunological response of the ani-
mal  to the parasitic infection, which is similar to that in
humans; this animal model also facilitates the evaluation
of  the methods in relation to the cure conﬁrmation, which
cannot  be tested in humans. N. squamipes is considered an
excellent  experimental model for S. mansoni studies (Souza
et  al., 1992; Maldonado et al., 1994).
Although there are several studies that have described
S. mansoni resistance to drugs and the recovery of
worms  after chemotherapy (Katz et al., 1973; Dias
et  al., 1978; Coelho et al., 1997; Conceic¸ ão et al., 2000;Burlandy-Soares et al., 2003; Silva et al., 2003; Pica-
Mattoccia and Cioli, 2004), the praziquantel dose used
was  effective at eliminating the S. mansoni parasites from
the  water rats without causing lethal effects. The dose
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Table 1
Results of the parasitological, immunological and molecular diagnostics and necropsy of N. squamipes experimentally infected with S. mansoni, before and after chemotherapy treatment with praziquantel.
Animals Before  infection After infection After treatment
ELISAa 22 days 50 days 1 month 3 months 6 months 12 months
ELISAa PCRc KKb ELISAa Necropsy KKb ELISAa PCRc ELISAa PCRc KKb ELISAa Necropsy PCRc ELISAa
Infected animals/treated
7809  0.6 7.4 29 5 18.5 Neg. 29.6 Neg. 7.6 Neg. Neg. 4.8 Neg. Neg. 3.4
7833  0.7 0.7 Neg. Neg. 0.6 Neg. 0.7 Neg. 0.2 Neg. Neg. 0.2 Neg. Neg. 0.1
9227 0.6 5.1  32 Neg. 11.9 Neg. 23.5 Neg. 5.0 Neg. Neg. 2.4 Neg. Neg. 1.5
10,702  0.7 8.9 Neg. 6 8.2 Neg. 29.9 Neg. 7.5 Neg. Neg. 4.0 NDb NDb NDb
10,703 ND 9.8 Neg. 2 21.2 Neg. 23.7 Neg. 6.3 Neg. Neg. 3.7 Neg. Neg. 3.0
10,708  0.7 2.5 Neg. 3 5.7 Neg. 10.3 Neg. 4.3 Neg. Neg. 1.9 Neg. Neg. 1.4
10,709  0.8 0.6 31 4 9.2 Neg. 5.9 Neg. 2.9 Neg. Neg. 1.8 Neg. Neg. 1.5
10,713 0.8  3.8 30 12 11.1 Neg. 10.9 3.0 Neg. Neg. 1.5 Neg. Neg. 1.9
10,731 0.6  6.7 27 13 6.4 Neg. 8.6 32 5.0 Neg. Neg. 2.4 Neg. Neg. 3.9
10,735 0.9  8.2 31 5 9.8 Neg. 15.6 Neg. 4.2 Neg. Neg. 2.3 Neg. Neg. 3.0
10,736 0.8  12.4 29 13 15.1 Neg. Neg. 25.8
9229  NF 18.2 32 Neg. 31.3 Neg. ND 41.7
9230 0.6 13.3  32 Neg. 14.0 Neg. Neg. 37.4
Infected  animals/no treated
10,710  0.7 7.4 30 4 5.0 1 8.4 Neg. 4.1 Neg. Neg. 5.3 Pos. Neg. 5.7
10,714  0.5 1.3 30 6 5.0 Neg. 6.8 31 3.8 34 5 2.6 Pos. 33 4.8
10,732  0.4 0.8 33 Neg. 0.5 Neg. ND Neg. 2.7 NDa NDa NDa Neg.
10,733 0.7 1.2 31 7 5.6 Neg. 9.1 33 1.5 NDb NDb NDb Neg.
10,737 0.5 15.0 32 3 17.3 Pos. Neg. 22.4
10,742 0.7 4.1 Neg. Neg. 4.2 Pos. 1 13.1
10,711  0.5 8.4 31 Neg. 2.0 Pos. Neg. 14.9
No  infected control animals
9228  0.7 0.8 Neg. Neg. 0.6 Neg. 0.8 Neg. 0.5 Neg. Neg. 0.2 Neg. Neg. 0.2
10,740  ND 0.7 Neg. Neg. 0.7 Neg. 0.9 Neg. 0.2 Neg. Neg. 0.2 Neg. Neg. 0.3
10,741  0.5 0.7 Neg. Neg. ND Neg. 0.6 Neg. 0.2 Neg. Neg. 0.2 Neg. Neg. 0.4
ND – exam not done; NDa – sacriﬁced animal; NDb – animal died.
a ELISA unit.
b Kato-Katz technique; number of eggs per gram of stool.
c PCR cycle threshold value (Ct).
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applied has been previously tested for this species in
other  experiments in our laboratory (Maldonado, per-
sonal  communication) and is less than the doses used in
other  experiments with mice (Fallon and Doenhoff, 1994;
Chaiworaporn et al., 2005).
Immunological  diagnosis using ELISA serology was very
efﬁcient in the detection of early infection, but it was
not  efﬁcient at evaluating the infection cure because IgG
antibodies were detected even at twelve months after
treatment. The qPCR technique produced a more accurate
result  when compared to the recommended test.
Parasitological and immunological results disagreed in
most  cases. The parasitosis can be detected by coproscopy
only six weeks after infection in contrast to serology, which
can  detect parasitosis 14 days after infection. To obtain a
positive  result of the parasitological diagnosis (to detect
the  presence of eggs in the feces), the parasite cycle must
be  completed within the deﬁnitive host with the develop-
ment of males and female adult worms, which reproduce
and produce the oviposition. Anti-S. mansoni antibodies can
be  promptly detected in the hosts if they are immune com-
petent,  which would provide an immunologic answer to
whether  or not parasites are present. Considering the more
advanced phases of the experiments, especially after treat-
ment,  both methods presented limitations. Although the
Kato-Katz  method is a 100% speciﬁc method, it was  not
sensitive enough to detect low burden infections which
resulted in false-negatives. However, serology could not
distinguish active infection from healed animals because
a  negative serum conversion was observed in only one
case.  Similarly, in humans, negative serum conversion after
treatment  is observed only after long periods of time
(Hamilton et al., 1998; Doenhoff et al., 2004). The slow
reduction in the antibodies after treatment and the exis-
tence  of cross-reactivity that result in false-positives are
the  major disadvantages of the immunological methods
(Pontes et al., 2002; Sorgho et al., 2005). Recently, evalu-
ation  of a commercially available antigen capture dipsticks
that  detects circulating cathodic antigen in urine has been
shown  to be an alternative method for diagnosis of schis-
tosomiasis in human and animal models (Van Dam et al.,
2004;  Stothard et al., 2011). This method also showed to
be  usefully as criteria for cure after speciﬁc treatment and
it  can be used as a complementary test in the diagnosis
of schistosomiasis in area with low egg burden (Stothard
et  al., 2006, 2011).
The  qPCR was a better diagnostic method for conﬁrm-
ing the cure of infection of S. mansoni although one of ten
animals  was misdiagnosed on the ﬁnal necropsy. In early
infection (50 days), this method was less efﬁcient than
serology but was slightly more efﬁcient than the Kato-Katz
method, which produced a few false-negatives. PCR-based
methods have provided high sensitivity and speciﬁcity
for the detection of the S. mansoni DNA in stool or urine
samples (Sandoval et al., 2006a,b; Ten Hove et al., 2008).
However, PCR demands a more sophisticated laboratory,
more complex operational efforts and higher costs (Rabello
et  al., 2002). In addition, PCR sometimes fails to detect pos-
itive  cases (Sandoval et al., 2006a,b; Allam et al., 2009). This
can  be attributed to ﬂuctuations in the elimination of par-
asite  eggs and parasite molecules, which can be inﬂuencedology 180 (2011) 243– 249
by  the intensity of infection (El Ridi et al., 1997). Sandoval
et  al., 2006a concluded that the PCR technique was more
sensitive for urine samples than for stool samples and that
it  is also more sensitive than the Kato-Katz and ELISA meth-
ods,  which is consistent with our results. Ten Hove et al.
(2008),  who  successfully applied the multiplex qPCR assay,
determined that this procedure should not be used for rou-
tine  diagnosis in endemic areas of S. mansoni due to its
relatively high cost.
The  question of obtaining a correct diagnosis of S. man-
soni  infection in patients in low endemic areas can be
reevaluated if we consider all the diagnostic possibilities
and their proper uses. Each diagnostic method has advan-
tages  for speciﬁc situations. In this study, we suggest that
the  methods should be used in low endemic areas as fol-
lows:  serology should be used in the initial diagnosis in
a  population with potential positive cases; subsequently,
coproscopy should be used in IgG positive cases to conﬁrm
the  current infection; and qPCR should be used to evalu-
ate  the cure of infection after treatment and is also a very
valuable tool when there are cases showing positive IgG
and  negative coproscopy, which commonly occurs in low
endemic  areas.
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